Boehringer Ingelheim Expands Idiopathic Pulmonary Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
Boehringer Ingelheim and Bridge Biotherapeutics Inc. announced that they are entering into a new collaboration...
Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety...
Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial...
CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
CURE Pharmaceutical , an innovative drug delivery and development company announced the allowance of U.S,...
Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
Cryoport and EVERSANA have announced a strategic alliance to further create a fully integrated regenerative...
Novartis key multiple sclerosis product Gilenya approved in China
"It is exciting news for MS patients in China that Gilenya has received fast approval....
Catalent Biologics Announces Agreement To Provide Additional Production Of Approved Gene Therapy Treatment For...
Catalent Biologics announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene...
Huge CPhI P MEC China a direct result of surging manufacturing
Organized by China Chamber of Commerce for Import & Export of Medicines & Health Products...
Swissport develops state-of-the-art pharma center at its brussels air cargo facility
Swissport is investing in a state-of-the-art air cargo facility at Brussels Airport. While Brussels Airport...
INTERPHEX Week Japan 2019 – a leading pharma industry event
Interview with Mr. Masaki Soda, Corporate Officer, and Mr. Kosaku Munetomo, International Sales Manager of...
New state of the art cleanroom completed by WHP for ADC bio
Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted...
